Direct emissions
13,065
tCO2e
Back to search resultsEmissions
Sustainability
Scope
REPORTED REPORTED ESTIMATED ESTIMATED REPORTED ESTIMATED REPORTED REPORTED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED 
Read the full scoring methodologyOur white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.Download the white paper (PDF)
Mycelium Score0.9 / 10Significant room to improveFTransparencyVery LowMinimal disclosure across key areas
Explore carbon emissions data for Apollo Hospitals. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Apollo Hospitals, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. It is one entry in the Mycelium emissions database. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
518,164tCO2e(Location Based)(Mycelium adjusted)
- Reported by Apollo Hospitals
- 156,962 tCO₂e
- Estimated by Mycelium
- 361,202 tCO₂e
Apollo Hospitals reported 30% of the adjusted total. Mycelium estimated the remaining 70% for the categories it did not disclose.
Scope 1
tCO2e
13,065
Scope 2 (Location Based)
tCO2e
112,024
Scope 3 total
tCO2e
393,075
Not yet checked against the source report
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Something wrong? Contribute to this dataset
See the scope breakdownProvenance
Emissions
Factors
0.169kgCO2e / $
Supplier specific emission factors (kgCO2e / $)
Modelled
Reported
UpstreamScope 1, 2 + upstream Scope 3
0.169
0.063
Total+ all Scope 3
–
0.063
Per US dollar of revenue. Mycelium models the upstream factor only.
Which figure should I use?
Estimating your own supply-chain emissions from spend with this company? Use Upstream Modelled. The GHG Protocol defines purchased-goods emissions as cradle-to-gate, which means this company's own operations plus its upstream supply chain. Any of those emissions the company has not disclosed are filled with modelled estimates, so a transparent company is not unfairly penalised against one that simply has not reported.
Looking at what the company filed itself? Use the Reported column. Total Reported also includes downstream emissions, such as the lifetime use of the products this company sells, which the GHG Protocol attributes to the users of those products rather than to customers buying goods and services.
Reported counts only emissions the company has filed itself. A blank or low Reported cell does not mean those emissions do not exist, just that the company has not disclosed them. When Upstream Reported sits close to Upstream Modelled, that is a positive signal: the company has disclosed most of its upstream emissions.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Apollo Hospitals reported 156,962 tCO₂e in 2025.
- Scope 3 accounted for 20% of reported emissions.
- Reported across 3 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the location based methodology.
According to available emissions disclosures, Apollo Hospitals reported total yearly emissions of 156,962 tCO₂e in 2025. Scope 2 emissions accounted for 71% of the reported footprint, indicating purchased energy was the most significant contributor to its carbon footprint.
The company achieved a Mycelium Score of 0.9, placing it well below average for its sector for sustainability performance, and received a transparency score of 35.1, pointing to very little public detail on their key emissions.
Scope
breakdown
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
112,024
tCO2eMarket based
–
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
183,291
tCO2eCat 2
Capital goods
31,911
tCO2eCat 3
Fuel & energy related activities
19,787
tCO2eCat 4
Upstream transportation & distribution
30,918
tCO2eCat 5
Waste generated in operations
10,698
tCO2eCat 6
Business travel
1,387
tCO2eCat 7
Employee commuting
17,409
tCO2eCat 8
Upstream leased assets
2,765
tCO2eCat 9
Downstream transportation & distribution
19,882
tCO2eCat 10
Processing of sold products
–
tCO2eCat 11
Use of sold products
47,935
tCO2eCat 12
End-of-life treatment of sold products
2,952
tCO2eCat 13
Downstream leased assets
8,024
tCO2eCat 14
Franchises
–
tCO2eCat 15
Investments
16,117
tCO2e10 values were derived via Mycelium's normalisation process rather than reported by the company. A cell marked “ESTIMATED” is a figure the company did not disclose, modelled by Mycelium. Cells marked “–” were not disclosed and could not be modelled.
Contact Info
Website
www.apollohospitals.comCountry
India
Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs peers in the same NACE section (emissions normalised against revenue, log-scaled between the 5th and 95th percentile of each company's latest reporting year in that section; a section needs at least 5 companies to be benchmarked). The band above 6.5 is earned through verified data quality on a claimed profile: declaring every reporting category yourself (up to 2.0), preparation by a carbon accountant (2.0) and independently audited figures (2.0). The total is multiplied by the transparency score and capped at 10. A disclosure with an implausibly large figure (Scope 1 or 2 over 300 million tonnes, a Scope 3 figure over 2 billion tonnes or a total over 2.5 billion tonnes) is not scored until it has been checked.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Apollo Hospitals's score sits at the top of this page and in the score panel. Without a revenue figure to measure carbon intensity, or an industry classification to compare it within, a company has no score.
How the Transparency Score is calculated
The Transparency Score is the share of a company's estimated footprint that it reported itself, graded from A (very high) down to F (very low). Where a category is missing, Mycelium models what it would hold for a company of that size and industry and counts it as undisclosed, so an unreported category where the bulk of emissions sit hurts far more than a minor one. Unreported downstream categories (9 to 15) count at a quarter of their modelled size in this share; the carbon intensity behind the score still counts them in full. A Scope 3 total filed without a category breakdown earns very little credit for the part left unattributed, because it does not show which categories are inside it: a company can count business travel, leave purchased goods out entirely, and the total looks the same. Without a revenue figure the footprint cannot be modelled, so the company has no Transparency Score.
For Apollo Hospitals, the single biggest gap is Purchased goods & services (Scope 3 Category 1). Mycelium estimates it accounts for around 35% of the company's estimated footprint, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
Other material categories Apollo Hospitals hasn't disclosed:
- Use of sold products (Scope 3 Category 11), around 9% of the estimated footprint
- Capital goods (Scope 3 Category 2), around 6% of the estimated footprint
- Upstream transportation & distribution (Scope 3 Category 4), around 6% of the estimated footprint
In total, roughly 70% of Apollo Hospitals's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodologyOur white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.Download the white paper (PDF)Compare Apollo Hospitals with similar companies
Apollo Hospitals carbon emissions FAQs
What are Apollo Hospitals's carbon emissions?
In its 2025 reporting year, Apollo Hospitals disclosed total emissions of 156,962 tCO2e across all scopes. Including Mycelium estimates for undisclosed categories, the adjusted total is 518,164 tCO2e. Scope 2 accounted for the largest share of the reported total, around 71%.
Does Apollo Hospitals report Scope 1, Scope 2 and Scope 3 emissions?
For 2025, Apollo Hospitals's available disclosure covers Scope 1 (13,065 tCO2e), Scope 2 (112,024 tCO2e) and Scope 3 across 3 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Apollo Hospitals's emissions reporting?
Apollo Hospitals has a Mycelium transparency score of 35.1 out of 100. The score is the share of the company's estimated footprint that it reported itself, so an undisclosed category where most of its emissions sit weighs far more than a minor one.
Is Apollo Hospitals sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Apollo Hospitals has a Mycelium Score of 0.9 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures and disclosure documents on this page give the fuller picture.
Is Apollo Hospitals environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Apollo Hospitals disclosed 156,962 tCO2e for 2025, and its Mycelium Score of 0.9 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.